Expanded Access of Occlutech's Atrial Flow Regulator
1 other identifier
expanded_access
N/A
1 country
1
Brief Summary
Occlutech AFR use allowed per FDA's Expanded Access program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2026
CompletedFirst Posted
Study publicly available on registry
February 19, 2026
CompletedFebruary 19, 2026
February 1, 2026
February 12, 2026
February 12, 2026
Interventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Individual Sites Across the U.S.
Maple Grove, Minnesota, 55369, United States
Central Study Contacts
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2026
First Posted
February 19, 2026
Last Updated
February 19, 2026
Record last verified: 2026-02